| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.43 | 0.0003 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.21 | 0.009 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |